Informance News 2007-08-23

Solarsoft MEI Home \| Request Information
Knowledge Base Benchmarking Boosting Lean Initiatives Enhancing Six Sigma Projects Driving OEE Improvements Case Studies White Papers Industry Articles Event Archives Product Demos
	Informance complements our strategic efforts to migrate all business unites to common platforms. Ron Christenson Cargill, Corporate VP and CTO EMI applications, such as Informance, generally begin to deliver value within days of being installed, offering an ROI that's measured in weeks and months, not years. Allison Smith AMR Research, Research Director We consistently strive for best-in-class manufacturing performance. Informance enables effective continuous improvement, which is key to manufacturing flexibility, low variability, and, ultimately, outstanding customer value. Ish Ahamed Diageo Plainfield, VP Supply Informance allows us to apply TPM loss elimination principles across our plants... We now have visibility of this information regardless of where you sit and can help replicate the improvement gains across multiple factories. Tony Lippert Unilever, Plant Manager Schienvar calls the Informance Manufacturing Intelligence Suite used at L'Oreal a 'beautiful tool.' Scott Schienvar L'Oreal, Logistic Director Informance gives us visibility into all of the facilities across our plant network to drive operational success. Steve Belke AkzoNobel, Supply Chain VP The competitive climate is changing at an increasing pace. Managers are drowning in data, but starving for relevant information. Carol Ptak Pacific Lutheran University, Former President APICS By focusing on operator-identified problems, we addressed the obstacles from each operation within the value stream. Pat Hatem JohnsonDiversey, Plant Manager We can show the cost of not spending capital at the push of a button. Rich Mosgrove Ventura, VP Manufacturing

Quick Info:

Registration:

Register for full access to:

Click to visit the
registration page.

BENCHMARK STUDY REVEALS IMPORTANT INSIGHT FOR MANUFACTURING PERFORMANCE IN PHARMACEUTICAL INDUSTRIES

Enterprise manufacturing intelligence data used to uncover strategies of top performing companies.

REDWOOD CITY, CA — August 23, 2007 — High performance pharmaceutical manufacturers outpace their peers in operational metrics such as asset utilization, overall equipment effectiveness (OEE), and operational availability, according to a report published by Informance International, a leader in Enterprise Manufacturing Intelligence (EMI). The six-month study of 50 worldwide pharmaceutical lines uncovered substantial gaps in performance for manufacturers that have granular, real-time visibility and measurement of key metrics versus those that do not.

The study revealed that best-in-class pharmaceutical enterprises outpace laggard performers in:

Operational availability by 77%,
Overall equipment effectiveness by 73%, and
Equipment failure by more than triple (7% of capacity vs. 26% for laggards)

Forging new ground in cross-industry benchmarking, researchers also examined pharmaceutical manufacturing performance in comparison to food and beverage manufacturing and discovered astonishing gaps in performance. They determined that best-in-class pharmaceutical manufacturers lag far behind best-in-class counterparts in the food and beverage industry in numerous metrics.

"Organizations involved in continuous improvement initiatives can benefit from this level of granular information," comments Bikash Chatterjee, President of Pharmatech Associates, a leading consulting firm in pharmaceutical biotech manufacturing process methodology.

Informance benchmark studies are unique because researchers use many months of real-time manufacturing performance data aggregated using the Informance Enterprise Manufacturing Intelligence platform. The highly granular and rich real-time nature of Informance EMI adds a new dimension for external and internal benchmarking initiatives.

"By correlating attributes of best-in-class performers across a variety of metrics, executives have the ability to gain insight and direction," comments John Oskin, Executive Vice President of Informance International. "Organizations can now understand how they stack up against their peers and develop an action plan for operational improvement."

To read the executive summary of this report, visit www.Informance.com/PharmaStudy.

Copyright © 2010 Solarsoft. All Rights Reserved.